Evidence map›Paper›PMID 35586493›Full record

ArticleFrontiers in oncology2022

Photodynamic Diagnosis for the Identification of Intestinal-Type Gastric Cancers and High-Grade Adenomas.

Hiroki Kurumi, Takuki Sakaguchi, Keiichi Hashiguchi, Taro Yamashita, Masashi Fujii, Yuichiro Ikebuchi, Akira Yoshida, Hajime Isomoto

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hiroki KurumiDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Takuki SakaguchiDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Keiichi HashiguchiDepartment of Endoscopy, Nagasaki University Hospital, Nagasaki, Japan.
Taro YamashitaDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Masashi FujiiDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Yuichiro IkebuchiDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Akira YoshidaDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Hajime IsomotoDivision of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Yonago, Japan.
Tottori University · JPNagasaki University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is the second most common cancer in Japan. The incidence of gastric cancer remains high owing to the increase in the elderly population. Endoscopy outperforms radiography in identifying early gastric cancer (EGC). Furthermore, image-enhanced endoscopy (IEE) has been developed and implemented worldwide in clinical practice. Magnifying IEE images can help to visualize the microvascular pattern and microstructure architecture, which is used for the characterization of EGC. However, accurate endoscopic diagnosis requires the experience and skill of endoscopists, making an objective and simple diagnostic method desirable. In this retrospective study, we investigated the diagnostic yield of 5-aminolevulinic acid (5-ALA)-mediated photodynamic diagnosis (PDD) for identifying gastric cancers and high-grade adenomas. In total, 52 lesions from 43 patients were ultimately included in the study. We detected 5-ALA-mediated protoporphyrin IX fluorescence in 45 of the 52 lesions that were initially intended for PDD, resulting in a detection rate of 86.5%, whereas each signet ring cell carcinoma was negative using 5-ALA PDD. In eight of the patients with multiple lesions, 17 lesions were identified using 5-ALA PDD. Again, we took biopsies from six areas that we suspected as new lesions. While 4 lesions were gastric neoplasms resected by endoscopic submucosal dissection, two other lesions were normal. Preoperative 5-ALA-PDD could provide additional diagnostic yields to detect such multiple lesions simultaneously. No severe adverse events were observed. Prospective multicenter studies are warranted to confirm the usefulness of 5-ALA PDD for EGC identification.

Indexed as

5-aminolevulinic acidendoscopygastric adenomagastric cancerphotodynamic diagnosis

Identifiers

PMID35586493
PMCPMC9108360
OpenAlexW4225276545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.